← All stocks

PALISADE BIO, INC.

PALI Net buying
CIK 0001357459 #3389 in the set updated 18 Sep 2026
Bought (120 mo)
$617.29K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$420.37K
$0.00 on a plan · $303.34K straight out of an exercise
Sold at will
$117.03K
4 of 5 sales
Net
+$196.92K
+$500.26K against sales at will

By person

19 insiders · 46 transactions
0.8×

J.D. Finley holds only 0.8 times base salary in stock. $477.38K of shares against $575.00K in salary for 2025.

Salary from the company's own proxy. The shares are what J.D. Finley last reported holding, valued at $1.96, the price Common Stock was last bought or sold at on the open market here, on 9 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Baltera Robert Jr.
Director
$250.18K (6)
+$250.18K
461,904
$903.48K
Finley John David
CEO, CFO
$101.50K (12)
$310.16K (2) scheduled
−$208.66K
244,061
$477.38K
Jones Mitchell Lawrence
Chief Medical Officer
$110.02K (2)
−$110.02K
94,009
$183.88K
Daly Richard J
Chief Executive Officer
$90.00K (7)
+$90.00K
23,312
$45.60K
Trenschel Robert J.
Director
$42.30K (5)
$192.00 (1)
+$42.11K
315,399
$616.92K
LLOYD JONES JONATHAN BRIAN
Chief Financial Officer
$40.00K (2)
+$40.00K
7,859
$15.37K
Williams Donald Allen
Director
$39.47K (5)
+$39.47K
1,600,294
$3.13M
Hallam Thomas
Chief Executive Officer
$36.74K (3)
+$36.74K
57,592
$112.65K
Dawson Michael John
Chief Medical Officer
$17.09K (1)
+$17.09K
15,000
$29.34K
Wei Binxian
Director
613,355
$1.20M
+30,667,650%
Chuang Emil
Director
612,500
$1.20M
Zwick Jordan Michael
Director
336,904
$658.98K
SMITH SANDFORD D
Director
219,916
$430.16K
+2,581%
WESTREICH STANLEY
Director
143,281
$280.26K
+14.9%
OLDAKER WILLIAM CLYDE
Director
33,763
$66.04K
+123.0%
Csimma Cristina
Director
12,862
$25.16K
+20,645%
Diaz Stephanie
Director
12,800
$25.04K
Neal James R
Director
10,920
$21.36K
McRae Robert Curtis
Chief Operating Officer
625
$1.22K
+160.4%

No percentages here. This company's share count has moved by a factor of 131.1 over the window, from 1,329,516 to 174,270,558 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Baltera Robert Jr.
9 Jul 2026
Director
Buy
25,000
$1.96
$48.90K
Baltera Robert Jr.
8 Jul 2026
Director
Buy
20,000
$1.99
$39.80K
Finley John David
7 Jul 2026
CEO, CFO
Sold after exercise
146,798
$2.07
$303.34K
Jones Mitchell Lawrence
7 Jul 2026
Chief Medical Officer
Sell
51,880
$2.05
$106.54K
Baltera Robert Jr.
7 Jul 2026
Director
Buy
30,000
$2.03
$61.04K
Baltera Robert Jr.
6 Jul 2026
Director
Buy
20,000
$2.05
$41.04K
Baltera Robert Jr.
2 Jul 2026
Director
Buy
10,000
$1.98
$19.80K
Baltera Robert Jr.
1 Jul 2026
Director
Buy
20,000
$1.98
$39.60K
Finley John David
12 Feb 2026
CEO, CFO
Sell
3,896
$1.75
$6.82K
Jones Mitchell Lawrence
12 Feb 2026
Chief Medical Officer
Sell
1,989
$1.75
$3.48K
Williams Donald Allen
16 Jan 2026
Director
Buy
5,000
$1.67
$8.36K
Williams Donald Allen
9 Jan 2026
Director
Buy
5,000
$1.88
$9.40K
Williams Donald Allen
28 May 2024
Director
Buy
1,000
$4.86
$4.86K
Finley John David
24 May 2024
CEO, CFO, Director
Buy
1,000
$4.81
$4.81K
Finley John David
6 Feb 2024
CEO, CFO, Director
Buy
10,000
$0.47
$4.69K
Williams Donald Allen
31 Jan 2024
Director
Buy indirect
10,000
$0.61
$6.05K
Finley John David
31 Jan 2024
CEO, CFO, Director
Buy
10,000
$0.56
$5.59K
Finley John David
27 Sep 2023
CEO, CFO, Director
Buy
15,000
$0.54
$8.09K
Williams Donald Allen
27 Sep 2023
Director
Buy indirect
20,000
$0.54
$10.80K
Trenschel Robert J.
14 Sep 2023
Director
Sell
300
$0.64
$192.00
Finley John David
13 Sep 2023
CEO, CFO, Director
Buy
15,000
$0.66
$9.83K
Finley John David
1 Sep 2022
Chief Financial Officer
Buy
19,481
$0.14
$2.80K
Finley John David
23 Aug 2022
Chief Financial Officer
Buy
7,350
$0.16
$1.18K
Finley John David
16 Aug 2022
Chief Financial Officer
Buy
100,000
$0.25
$25.00K
Hallam Thomas
16 Aug 2022
Chief Executive Officer
Buy
40,000
$0.25
$10.00K
Dawson Michael John
29 Mar 2022
Chief Medical Officer
Buy
15,000
$1.14
$17.09K
Hallam Thomas
28 Mar 2022
Chief Executive Officer
Buy
10,000
$1.18
$11.80K
Finley John David
24 Mar 2022
Chief Financial Officer
Buy
7,500
$1.09
$8.17K
Hallam Thomas
21 Sep 2021
Chief Executive Officer
Buy
6,000
$2.49
$14.94K
Finley John David
21 Sep 2021
Chief Financial Officer
Buy
2,000
$2.44
$4.88K
Trenschel Robert J.
10 Sep 2021
Director
Buy
2,142
$2.98
$6.38K
Trenschel Robert J.
9 Sep 2021
Director
Buy
3,400
$2.89
$9.83K
Trenschel Robert J.
8 Sep 2021
Director
Buy
5,000
$2.75
$13.75K
Trenschel Robert J.
7 Sep 2021
Director
Buy
2,707
$2.78
$7.53K
Trenschel Robert J.
31 Aug 2021
Director
Buy
1,750
$2.75
$4.81K
Finley John David
27 Aug 2021
Chief Financial Officer
Buy
8,400
$2.65
$22.26K
Finley John David
27 Aug 2021
Chief Financial Officer
Buy
1,600
$2.63
$4.21K
Daly Richard J
17 May 2017
Chief Executive Officer
Buy
7,500
$4.00
$30.00K
LLOYD JONES JONATHAN BRIAN
24 Mar 2017
Chief Financial Officer
Buy
5,455
$5.50
$30.00K
Daly Richard J
24 Feb 2017
Chief Executive Officer
Buy
2,591
$3.86
$10.00K
Daly Richard J
25 Jan 2017
Chief Executive Officer
Buy
2,841
$3.52
$10.00K
Daly Richard J
23 Dec 2016
Chief Executive Officer
Buy
32,259
$0.31
$10.00K
Daly Richard J
25 Nov 2016
Chief Executive Officer
Buy
35,715
$0.28
$10.00K
Daly Richard J
25 Oct 2016
Chief Executive Officer
Buy
35,715
$0.28
$10.00K
Daly Richard J
23 Sep 2016
Chief Executive Officer
Buy
31,250
$0.32
$10.00K
LLOYD JONES JONATHAN BRIAN
23 Sep 2016
Chief Financial Officer
Buy
31,250
$0.32
$10.00K

What was left out

Form 4 filings counted 153
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 4,855,018
History held since 26 Sep 2016